Therapeutics Company Reports Promising Interim Data For Metastatic Pancreatic Cancer

Groundbreaking Advancement in Pancreatic Cancer Treatment: A Closer Look at Candel Therapeutics' CAN-2409.

Disclaimer: All information provided below is based on data available as of the publication date and is intended for informational purposes only. Consult healthcare professionals for personalized medical advice.